We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
VistaGen Therapeutics Inc | NASDAQ:VTGN | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.09 | 2.04% | 4.50 | 4.30 | 4.56 | 4.55 | 4.31 | 4.47 | 189,633 | 21:02:01 |
NEVADA
|
000-54014
|
20-5093315
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(IRS Employer Identification Number)
|
343 Allerton Ave.
South San Francisco, California 94090
|
(Address of principal executive offices)
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which
registered
|
Common
Stock, par value $0.001 per share
|
VTGN
|
Nasdaq
Capital Market
|
Exhibit No.
|
|
Description
|
|
|
|
|
Underwriting
Agreement, dated August 2, 2020, by and between VistaGen
Therapeutics, Inc. and Maxim Group LLC
|
|
|
Opinion of Disclosure Law Group, a Professional
Corporation
|
|
|
Consent of Disclosure Law Group, a Professional Corporation
(included in Exhibit 5.1)
|
|
|
Press Release issued by VistaGen Therapeutics, Inc. to announce
pricing of the Public Offering, dated August 2, 2020.
|
|
|
Press Release issued by VistaGen Therapeutics, Inc. to announce the
closing of the Public Offering, dated August 5, 2020.
|
|
|
Press Release issued by VistaGen Therapeutics, Inc. to announce
receipt of the upfront license payment from EverInsight
Therapeutics, Inc., dated August 3, 2020.
|
|
VistaGen
Therapeutics, Inc.
|
|
|
|
|
Date:
August 5, 2020
|
By:
|
/s/ Shawn K. Singh
|
|
|
Shawn
K. Singh
Chief
Executive Officer
|
1 Year VistaGen Therapeutics Chart |
1 Month VistaGen Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions